Try our beta test site
1 study found for:    CAFQ056A2299
Show Display Options
Rank Status Study
1 Completed Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Conditions: Dyskinesias;   Parkinson Disease;   Movement Disorders;   Parkinsonian Disorders;   Anti-Dyskinesia Agents
Intervention: Drug: AFQ056

Study has passed its completion date and status has not been verified in more than two years.